(Q50074491)

English

Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen

scientific article published on 28 December 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

Ladaporn Bodhidatta

16

object named as

Ladaporn Bodhidatta

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

4

object named as

Carl Mason

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

author name string

David R Tribble

1

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

John W Sanders

2

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Lorrin W Pang

3

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Chittima Pitarangsi

5

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Shahida Baqar

6

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Adam Armstrong

7

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Paul Hshieh

8

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Anne Fox

9

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Elisabeth A Maley

10

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Carlos Lebron

11

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Dennis J Faix

12

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

James V Lawler

13

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Gautam Nayak

14

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Michael Lewis

15

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Daniel A Scott

17

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

language of work or name

0 references

publication date

28 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

44

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

3

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

338-346

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Antimicrobial-resistant Campylobacter species--a new threat to travelers to Thailand.

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Single dose of azithromycin or three-day course of ciprofloxacin as therapy for epidemic dysentery in Kenya. Acute Dysentery Study Group

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Alterations in apoptosis of cord and adult peripheral blood mononuclear cells induced by in vitro infection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Typical and atypical enteropathogenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Intracellular activity of azithromycin against bacterial enteric pathogens

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Disposition of oral azithromycin in humans*

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

The safety of azithromycin in the treatment of adults with community-acquired respiratory tract infections

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

In-vitro activity of DR-3355, an optically active isomer of ofloxacin, against bacterial pathogens associated with travellers' diarrhoea

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Campylobacter and fluoroquinolones: a bias data set?

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Prevention and Treatment of Traveler's Diarrhea: A Clinical Pharmacological Approach (Part 1 of 2)

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Coinfection with Campylobacter species: an epidemiological problem?

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994.

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA,1982-2001.

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1086%2F510589

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17205438

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50074491&oldid=2238257604"